Back to Search
Start Over
alpha5 Subunit-containing GABA(A) receptors mediate a slowly decaying inhibitory synaptic current in CA1 pyramidal neurons following Schaffer collateral activation.
- Source :
-
Neuropharmacology [Neuropharmacology] 2010 Mar; Vol. 58 (3), pp. 668-75. Date of Electronic Publication: 2009 Nov 23. - Publication Year :
- 2010
-
Abstract
- GABA(A) receptors that contain the alpha5 subunit (alpha5GABA(A)Rs) are highly expressed in the hippocampus, and have been implicated in learning and memory processes. They generate a tonic form of inhibition that regulates neuronal excitability. Recently it was shown that alpha5GABA(A)Rs also contribute to slow phasic inhibition of CA1 pyramidal neurons following local stimulation in the stratum lacunosum moleculare. However, it is unknown whether alpha5GABA(A)Rs can also be recruited indirectly by stimulation of Schaffer collaterals. Here, we studied GABAergic currents evoked by stimulation in the stratum radiatum of CA1 in the presence and absence of CNQX to block AMPA receptor-mediated excitation. We tested their sensitivity to gabazine and two drugs acting at the benzodiazepine site of alpha1/alpha2/alpha3 or alpha5GABA(A)Rs (400 nM zolpidem and 20 nM L-655,708, respectively). IPSCs evoked by stimulation in the stratum radiatum in the presence of CNQX were potentiated by zolpidem, blocked by 1 muM gabazine and were relatively insensitive to L-655,708 consistent with the lack of alpha5GABA(A)Rs. In contrast, IPSCs evoked by stimulation of Schaffer collaterals had a significant gabazine-insensitive component. This component was attenuated by L-655,708 and enhanced by burst stimulation. Furthermore, the L-655,708-sensitive current was absent in recordings from mice lacking alpha5GABA(A)Rs (gabra5(-/-) mice). These results show that alpha5GABA(A)R-mediated phasic inhibition is activated by the Schaffer collateral pathway and provide evidence for activity pattern-dependent participation of alpha5GABA(A)Rs in inhibition.<br /> (Copyright 2009 Elsevier Ltd. All rights reserved.)
- Subjects :
- 6-Cyano-7-nitroquinoxaline-2,3-dione pharmacology
Animals
Animals, Newborn
Dose-Response Relationship, Drug
Electric Stimulation methods
Excitatory Amino Acid Agonists pharmacology
Excitatory Amino Acid Antagonists pharmacology
GABA Agonists pharmacology
GABA Antagonists pharmacology
Imidazoles pharmacology
In Vitro Techniques
Inhibitory Postsynaptic Potentials drug effects
Inhibitory Postsynaptic Potentials genetics
Male
Mice
Mice, Knockout
N-Methylaspartate pharmacology
Neural Inhibition drug effects
Neural Inhibition genetics
Neural Pathways drug effects
Neural Pathways physiology
Pyramidal Cells drug effects
Pyridazines pharmacology
Pyridines pharmacology
Rats
Rats, Sprague-Dawley
Reaction Time drug effects
Receptors, GABA-A deficiency
Zolpidem
CA1 Region, Hippocampal cytology
Inhibitory Postsynaptic Potentials physiology
Neural Inhibition physiology
Pyramidal Cells physiology
Receptors, GABA-A physiology
Subjects
Details
- Language :
- English
- ISSN :
- 1873-7064
- Volume :
- 58
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Neuropharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 19941877
- Full Text :
- https://doi.org/10.1016/j.neuropharm.2009.11.005